A Multistrain Probiotic in Patients With Irritable Bowel Syndrome With Predominant Constipation

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

December 9, 2022

Study Completion Date

December 9, 2022

Conditions
Irritable Bowel Syndrome With Constipation
Interventions
DIETARY_SUPPLEMENT

Probiotics mixture

"12 weeks of daily supplementation with 1 g of probiotics mixture (4.10exp9 colony forming unit/g) containing:~* Bifidobacterium longum LA 101~* Lactobacillus helveticus La 102~* Lactococcus lactis LA 103~* Streptococcus thermophilus LA 104"

Trial Locations (1)

21000

CEN Nutriment, Dijon

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

PiLeJe

INDUSTRY

lead

CEN Biotech

INDUSTRY

NCT04997057 - A Multistrain Probiotic in Patients With Irritable Bowel Syndrome With Predominant Constipation | Biotech Hunter | Biotech Hunter